Rentocertib

…that quietly disappear when the hard clinical trial data finally comes back negative? There is one landmark example worth knowing, because a company called Insilico Medicine developed a drug called Rentocertib, and it became the first molecule with both an AI-discovered target and an AI-designed compound to publish peer-reviewed phase 2A results.…